From Yahoo Finance: 2025-06-11 19:35:00

Vertex Pharmaceuticals Incorporated is highlighted as one of the 13 Biotech Stocks with Huge Upside Potential, sharing new data at a cystic fibrosis conference showing positive outcomes with ALYFTREK®. A study found that lower sweat chloride levels were linked to improved lung function and quality of life. Approximately 109,000 people worldwide have cystic fibrosis, with most having the F508del mutation. Vertex is donating TRIKAFTA® in lower-income countries and serving over 75,000 patients in 60+ countries. While Vertex shows promise as an investment, some AI stocks may offer greater potential. No promotional or marketing content included.



Read more at Yahoo Finance: Vertex Presents New Data on the Benefits of ALYFTREK